| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.4B | $6.1B | $5.7B | $6.0B | $6.9B | $6.1B | $6.1B | $5.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-0.7B | $0.8B | $-0.4B | $1.3B | $1.8B | $0.9B | $0.8B | $1.2B |
| Net Income | $-0.2B | $0.5B | $-0.3B | $0.7B | $1.4B | $0.5B | $0.6B | $0.9B |
| EPS (Basic) | $-1.60 | $1.18 | $-0.73 | $1.50 | $3.01 | $1.14 | $1.29 | $2.14 |
| EPS (Diluted) | $-1.60 | $1.18 | $-0.73 | $1.49 | $2.99 | $1.13 | $1.28 | $2.14 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $27.1B | $27.0B | $28.9B | $29.8B | $32.7B | $36.5B | $39.4B | $31.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.0B | $1.0B | $1.5B | — | $1.9B | $1.4B | $1.0B | $1.1B |
| Total Liabilities | $14.1B | $11.3B | $13.0B | $12.9B | $16.0B | $21.5B | $24.7B | $21.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $12.2B | $14.6B | $14.6B | $15.2B | $15.5B | $14.4B | $13.9B | $8.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.2B | $1.3B | $0.7B | $1.1B | $1.2B | $1.1B | $0.8B |
| Investing Cash Flow | $-1.0B | $0.1B | $-0.2B | $-0.4B | $-0.8B | $-0.9B | $-1.4B | $-2.9B |
| Capital Expenditures | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.1B | $-1.7B | $-0.6B | $-1.0B | $0.1B | $-0.3B | $0.2B | $1.5B |